/Companies

Peptomyc

Barcelona, ES · 5 known investors

Find your way into Peptomyc

Sign up to see every warm intro you have to Peptomyc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Peptomyc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.

Founders & leadership

DMDr. Marie-Eve Beaulieu
Dr. Marie-Eve BeaulieuCo-founder
LSLaura Soucek
Laura SoucekCo-founder & CSO (former CEO)

Investors · 5

Also in the syndicate · 1

EIT Health

In the news

Frequently asked questions

What does Peptomyc do?
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
Who founded Peptomyc?
Peptomyc was founded by Dr. Marie-Eve Beaulieu, Laura Soucek.
Who are Peptomyc's investors?
Peptomyc's investors include Asabys Partners, Aurora Science, Invivo Capital Partners, Alta Life Sciences.
Where is Peptomyc headquartered?
Peptomyc is headquartered in Barcelona, ES.